Status:
COMPLETED
Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease
Lead Sponsor:
Baylor University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Cognitive Impairment, Mild
Eligibility:
All Genders
Phase:
NA
Brief Summary
Alzheimer's disease is a debilitating condition for patients and their caregivers marked by hallmark cognitive symptoms (e.g., memory loss) as well as an impact on quality of life. Researchers and cli...
Eligibility Criteria
Inclusion
- Diagnosis of MCI or dementia at a neurology and/or neuropsychology office visit in the BSWH Temple region, or neuropsychology office visit in the RR BSWH region within 12 months of the study contact (Specific ICD Codes outlined below).
- Interest in participating in research
- Able and willing to bring a legally authorized representative (spouse or medical power of attorney) to initial training session.
- Able to independently consent according to the results of a structured capacity to consent interview OR is interested after going through the consent process but does not pass capacity to consent inventory AND has a legally authorized representative available to provide proxy consent.
- Presence of no more than mild dementia on the basis of telephone administered cognitive screening instrument (TICS-M) \& Collateral/Informant ADL Measure
- o Using the TICS-M and published normative data, all subjects must have scores that are around -1 to -2 standard deviations for demographically corrected norms (National Institute of Aging-Alzheimer's Association recommended criteria for the very mild to mild stages of Alzheimer's disease; Albert et al., 2011; McKhann et al., 2011).
- Etiology of the dementia or MCI can be varied or unknown at the time of the screening criteria.
Exclusion
- Presence of severe cognitive impairment defined by a TICS-M score \<-2 standard deviations from the mean.
- Semi-structured telephone clinical interview and/or chart review suggest:
- Serious mental illness (schizophrenia, bipolar, or depression with suicidal ideation in the last 30 days) are present and significantly contributing to the current presentation
- Uncorrected hearing loss, visual loss, or motoric dysfunction would preclude using the smartphone.
- English language proficiency (whether due to English as a second language or the presence of aphasia) significantly interferes with completion of telephone screening procedures or would be clinically suspected to interfere with completion of the study process.
Key Trial Info
Start Date :
January 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03384043
Start Date
January 8 2018
End Date
February 28 2020
Last Update
July 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Scott & White Medical Center
Temple, Texas, United States, 76508